Avo Raises $10M Series A for Clinical AI Platform

Avo, a clinical intelligence platform designed to streamline decision-making for healthcare professionals, has successfully closed a $10 million Series A funding round. The investment was spearheaded by Noro-Moseley Partners, with significant contributions from existing backers AlleyCorp, Las Olas Venture Capital, MedMountain Ventures, and Epsilon Health. New participant Scrub Capital also joined the round, bringing the company's total equity funding to $18 million.

The infusion of capital is earmarked to accelerate Avo's mission of transforming Electronic Health Records (EHRs) into dynamic tools that actively support clinicians. Founded by a team of physicians including CEO Dr. Yair Saperstein, the company aims to embed evidence-based guidance directly into the clinical workflow, addressing critical needs identified during their own practice experiences. This strategic funding will fuel the expansion of their AI-powered solutions, designed to augment clinician capabilities at the crucial point of care.

Avo's platform integrates seamlessly with major EHR systems such as Epic, athenahealth, and MEDITECH. It offers AI copilots, including 'Chart Assist' and 'Ask Avo,' which provide real-time support across a spectrum of clinical activities, from patient admission and discharge to documentation and medication management. This focus on workflow integration is key in a healthcare environment increasingly reliant on digital tools to manage complex patient data.

The impact of Avo's technology is already evident through measurable outcomes achieved by its healthcare partners. These include substantial cost savings, such as $11.6 million for a multinational ambulatory organization, and significant efficiency gains like a 35% reduction in documentation time per patient at a major hospital. Furthermore, the platform has demonstrated its ability to enhance revenue cycles, contributing to $7.5 million in increased annual reimbursement for clinical documentation improvement at an academic medical center, and boosting outpatient encounter completion rates by 28%.

In a move that further solidifies its commitment to evidence-based practice, Avo also announced a strategic alliance with EBSCO Clinical Decisions. This collaboration will integrate DynaMed's extensive, peer-reviewed clinical knowledge base directly into Avo's AI-driven workflow. This synergy promises to deliver curated, up-to-date medical information precisely when and where clinicians need it, reinforcing the platform's value proposition in supporting informed medical decisions.

The broader healthcare technology sector is witnessing a significant push towards AI solutions that can alleviate clinician burnout and improve patient outcomes. With an estimated market for AI in healthcare projected for substantial growth in the coming years, Avo's focus on practical, workflow-embedded tools positions it to capture a significant share. The company's ability to demonstrate tangible financial and operational benefits, coupled with strategic partnerships, underscores its potential to become a leader in this rapidly evolving space.